D. F. Tai

A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer

Higinia R. Cárdenes, Annette M. Moore, Cynthia S. Johnson et al. · American Journal of Clinical Oncology · 2010 · 76 citations

Phase 2 study of tabalumab, a human anti‐B‐cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma

Noopur Raje, Philippe Moreau, Evangelos Terpos et al. · British Journal of Haematology · 2016 · 48 citations

Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer

Andrew D. Seidman, Adam Brufsky, Rafat Ansari et al. · Annals of Oncology · 2010 · 33 citations · Full text

Metastatic Breast Cancer, Oncology, Medicine +8

Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer

Alan N. Gordon, Michael Teneriello, Mike F. Janicek et al. · Gynecologic Oncology · 2011 · 26 citations

Induction Gemcitabine, Medicine, Pharmacology +8

Interferon-α2a and 13-cis-retinoic acid with radiationtreatment for high-grade glioma

Robert O. Dillman, William M. Shea, D. F. Tai et al. · Neuro-Oncology · 2001 · 26 citations · Full text